Immunotherapy Combinations for Lung Cancers: Challenges and Opportunities of Rapidly Evolving Treatments

AACR Lung IO Combo Program Image
Download All
Few oncology treatment paradigms are evolving as rapidly as those for lung cancer. In particular, emerging data and indications for immunotherapy combinations in both NSCLC and SCLC have resulted in an explosion of new therapeutic options. Review the program Webcast and download the slidesets to deepen your understanding of current and evolving best practices! This is not an official program of the American Association for Cancer Research Annual Meeting.
H. Jack West, MD
Program Director
Hossein Borghaei, MS, DO
Stephen V. Liu, MD

Downloadable Slidesets

Download this slideset from a symposium during the AACR annual meeting in Atlanta reviewing the current and future management of small-cell lung cancer with immune checkpoint inhibitors and chemotherapy.

Stephen V. Liu, MD Released: April 1, 2019

Download this slideset from a symposium during the AACR annual meeting in Atlanta reviewing the current and future management of non-small-cell lung cancer with immune checkpoint inhibitors and chemotherapy.

H. Jack West, MD
Program Director
Released: April 1, 2019

Download this slideset from a symposium during the AACR annual meeting in Atlanta reviewing the role of immune checkpoint inhibitors and chemotherapy in the future management of patients with lung cancer,

Hossein Borghaei, MS, DO Released: April 1, 2019
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Genentech

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue